VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10013889 | HBV | ENSG00000012124.17 | protein_coding | CD22 | No | No | 933 | P20273 Q0EAF5 |
TVIS30082490 | HIV | ENSG00000012124.17 | protein_coding | CD22 | No | No | 933 | P20273 Q0EAF5 |
TVIS20009984 | HPV | ENSG00000012124.17 | protein_coding | CD22 | No | No | 933 | P20273 Q0EAF5 |
TVIS20068354 | HPV | ENSG00000012124.17 | protein_coding | CD22 | No | No | 933 | P20273 Q0EAF5 |
TVIS20016744 | HPV | ENSG00000012124.17 | protein_coding | CD22 | No | No | 933 | P20273 Q0EAF5 |
TVIS44018189 | HTLV-1 | ENSG00000012124.17 | protein_coding | CD22 | No | No | 933 | P20273 Q0EAF5 |
TVIS44033835 | HTLV-1 | ENSG00000012124.17 | protein_coding | CD22 | No | No | 933 | P20273 Q0EAF5 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | CD22 |
---|---|
DrugBank ID | DB05889 |
Drug Name | Inotuzumab ozogamicin |
Target ID | BE0000183 |
UniProt ID | P20273 |
Regulation Type | antibody |
PubMed IDs | 28152223; 33807678 |
Citations | Thota S, Advani A: Inotuzumab ozogamicin in relapsed B-cell acute lymphoblastic leukemia. Eur J Haematol. 2017 May;98(5):425-434. doi: 10.1111/ejh.12862. Epub 2017 Mar 9.@@Kyriakidis I, Vasileiou E, Rossig C, Roilides E, Groll AH, Tragiannidis A: Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies. J Fungi (Basel). 2021 Mar 5;7(3). pii: jof7030186. doi: 10.3390/jof7030186. |
Groups | Approved; Investigational |
Direct Classification | Peptides |
SMILES | |
Pathways | |
PharmGKB | |
ChEMBL |